CLASS III Drug recall · Reported 27 Apr 2016 · FDA Enforcement Report

Telmisartan Tablets, USP, 80 mg ( unit-dose blisters) recalled

Torrent Pharmaceuticals is recalling Telmisartan Tablets, USP, 80 mg ( unit-dose blisters) per, distributed nationwide in the US. The recall was initiated on 25 Feb 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot#: BBV8B002R, Exp 12/16
Quantity recalled20,952 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0824-2016
FDA event ID
73466
Recalling firm
Torrent Pharmaceuticals, Kadi, N/A
Classification
Class III
Status
Terminated
Recall initiated
25 Feb 2016
FDA classified
18 Apr 2016
Reported
27 Apr 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

25 Feb 2016Recall initiated by company
18 Apr 2016Classified by FDA+53 days
27 Apr 2016Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Telmisartan Tablets, USP, 80 mg, 30-count (3 x 10 unit-dose blisters) per carton, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, Dist. Mehsana, INDIA.; For: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, NDC 13668-158-72, UPC 3 13668 158 72 4.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.

Which lots are affected?

Lot#: BBV8B002R, Exp 12/16

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Telmisartan recalls

All 11